期刊文献+

结核感染T细胞斑点实验对结核性胸膜炎的诊断价值 被引量:2

Diagnostic value of T-SPOT.TB for tuberculous pleurisy
下载PDF
导出
摘要 目的研究结核感染T细胞斑点实验(T—SPOT.TB)对结核性胸膜炎患者的诊断价值。方法比较T—SPOT.TB、ADA检测110例渗出性胸腔积液患者的阳性率、灵敏度、特异度、阳性预测值、阴性预测值等;比较治疗前后T—SPOT.TB斑点数的变化。结果T—SPOT.TB检测结核性胸膜炎患者的灵敏度、特异度、阳性预测值、阴性预测值、约登指数分别为89.66%、86.54%、88.14%、88.24%、0.76。ADA检测的灵敏度、特异度、阳性预测值、阴性预测值、约登指数分别为74.14%、75.00%、76.79%、72.22%、0.49。T—SPOT.TB的灵敏度、特异度明显高于ADA,差异有统计学意义(均P〈0.05)。抗结核治疗后的结核性胸膜炎患者经ESAT-6和CFP-10刺激产生的斑点数明显低于抗结核治疗前(均P〈0.05)。结论T—SPOT.TB对结核性胸膜炎有较好的辅助诊断价值,在抗结核治疗效果监测方面有一定的指导意义。 Objective To explore the value of T-SPOT.TB test in the diagnosis of tuberculous pleurisy. Methods The positive rate, sensitivity, specificity, positive predictive value, and negative predictive value of T-SPOT.TB and ADA were calculated and compared. Among these patients, 40 were retested by T-SPOT.TB after anti-tuberculosis treatment; and spot forming cells (SFCs) were compared before and after the treatment. Results The sensitivity, specificity, positive predictive value, and negative predictive value of T-SPOT.TB were 89.66%, 86.54%, 88.14%, 88.24%, and 0.76. And those of ADA were 74.14%, 75.00%, 76.79%, 72.22%, and 0.49. The sensitivity and specificity of T-SPOT.TB were significantly higher than those of ADA, with statistical differences (P〈0.05). 40 patients were retested by the T-SPOT.TB after anti-TB treatment, and the results showed that ESAT- 6 and CFP-10 specific SFCs decreased significantly compared with those before anti-TB treatment (P〈0.05). Conclusion T-SPOT.TB assay has an important clinical value in the diagnosis of tuberculous pleurisy and help us monitor treatment response.
出处 《国际医药卫生导报》 2018年第4期520-523,共4页 International Medicine and Health Guidance News
关键词 T—SPOT.TB ADA 结核性胸膜炎 诊断价值 T-SPOT.TB ADA Tuberculouspleurisy Diagnostic value
  • 相关文献

参考文献4

二级参考文献53

  • 1史可云,胡忠义.酶联免疫斑点技术在结核病诊断中的应用现状[J].中华结核和呼吸杂志,2006,29(6):414-416. 被引量:25
  • 2乐军,梁莉,李苏辉,张跃建,肖和平.酶联免疫斑点试验快速诊断结核分枝杆菌感染的临床应用价值[J].中华检验医学杂志,2006,29(11):1005-1008. 被引量:70
  • 3Light RW. Update on tuberculous pleural effusion. Respirology, 2010, 15:451-458.
  • 4Light RW. Clinical practice. Pleural effusion. N Engl J Med, 2002, 346 : 1971-1977.
  • 5Dalbeth N, Lee YC. Lymphocytes in pleural disease. Curr Opin Pulm Med, 2005, 11:334-339.
  • 6Jantz MA, Antony VB. Pathophysiology of the pleura. Respiration, 2008, 75:121-133.
  • 7Porcel JM. Tuberculous pleural effusion. Lung, 2009, 187:263- 270.
  • 8Ye ZJ, Yuan ML, Zhou Q, et al. Differentiation and recruitment of Th9 cells stimulated by pleural mesothelial cells in human Mycobacterium tuberculosis infection. PLoS One, 2012, 7: e31710.
  • 9Ye ZJ, Zhou Q, Yuan ML, et al. Differentiation and recruitment of IL-22-producing helper T cells stimulated by pleural mesothelial cells in tuberculous pleurisy. Am J Respir Crit Care Med, 2012, 185:660-669.
  • 10Stathopoulos GT, Kalomenidis I. Malignant pleural effusion: tumor-host interactions unleashed. Am J Respir Crit Care Med, 2012, 186:487-492.

共引文献150

同被引文献18

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部